You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company was originally founded as a spinoff from Korean genomic services provider Macrogen to offer direct-to-consumer genomic rare disease screening tests.
Data from more than 11,800 women with breast cancer suggested unselected BRCA1, BRCA2, and PALB2 testing is cost-effective for UK and US payors and societies.
The company claims that certain Illumina sequencers infringe its US Patent No. 9,944,984, "Methods and Compositions for Efficient Base Calling in Sequencing Reactions."
In PNAS this week: cell line to assay myotonic dystrophy type 1 therapies, gene involved in rice architecture, and more.
In PLOS this week: genetic analysis of Iranian ethnic groups, genome-wide methylation analysis of cataracts among giant pandas, and more.
The team identified six independent DNA methylation blocks that could potentially help to predict the formation of central nervous system metastases in lung cancer.
Gathering last week in Australia, the community continued its years-long push towards increased clinical relevance and integration with other omics disciplines.
Personal Genomics alleged that PacBio tried to sublicense the patent-in-suit in the years prior to its launch of the Sequel sequencing platform.
A Japanese Kobe beef industry group is to begin using DNA testing to fight against fake Kobe beef, according to Kyodo News.
Researchers have developed a robotic lab assistant, the Verge reports.
CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.
The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.
In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.